newsfilter
← Latest News
GlobeNewswire·

Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

  • Tenax Therapeutics (NASDAQ: TENX) will participate in a fireside chat at the 2026 Leerink Partners Global Healthcare Conference in Miami, FL, held from March 8-11, 2026.
  • The presentation is scheduled for March 10, 2026, at 2:20 p.m. ET.
  • Participants in the session include CEO Chris Giordano, CMO Stuart Rich, M.D., & Chief Business Officer Douglas Randall.
  • The live & archived webcast will be available on the company's investor relations webpage.
  • Tenax Therapeutics is a Phase 3 development-stage pharmaceutical company focusing on novel cardiopulmonary therapies.
  • The company holds global rights to develop levosimendan for PH-HFpEF, the most prevalent form of pulmonary hypertension globally, for which no product has been approved to date.